US stocks edged higher on Monday as investors eyed a looming US government shutdown that risks delaying the release of the all-important monthly jobs report later in the week. The S&P 500 gained 0.3%, Nasdaq rose 0.5%, and the Dow Jones Industrial Average rose almost 0.2%. Markets are assessing the odds of a shutdown, with Trump setting a meeting with congressional leaders. The Department of Labor announced that the Bureau of Labor Statistics will “suspend all operations,” affecting key economic data releases. The BLS’s monthly job updates and inflation reports have been crucial for the Federal Reserve’s policy setting. Last week’s jobless claims fell short, fueling speculation on interest rate cuts. Investors regroup after a losing week, with AI-focused stock trading cracks and surprise tariff announcements from Trump. Despite that, stocks are on pace to finish September and the third quarter with gains. Gold rose to new records, up 45% this year. Bitcoin surged above $113,000, while Ethereum and Solana also rose. It’s not just gold having a monster year; silver has surged even more, up over 60% year-to-date. The price of silver is not far off its all-time high record closing price. Treasury Secretary counselor says Fed rate cut is needed for the economy as worries continue about tariffs. A wave of leadership changes swept through Wall Street on Monday, with CEOs out at GSK, Comcast, Barrick, Newmont, and CSX. A record year for CEO changes, with 1,358 CEOs leaving their posts so far in 2025. Trump’s latest tariff threats aimed at foreign movies and furniture. Home contract signings jumped in August as mortgage rates dropped. BLS to ‘suspend all operations,’ putting jobs, inflation reports in limbo. Dallas Fed’s index for Texas manufacturing activity drops more than expected. Intel stock falls, ending rally. Nvidia stock rises, eyes fresh record. Cannabis stocks surge after Trump appears to back CBD for senior healthcare. Alibaba stock rises after bullish analyst calls on AI, cloud. EA stock jumps on $55 billion acquisition deal. MoonLake stock poised for huge wipeout after drug trial disappoints. Premarket trending tickers: Canopy Growth, GSK, and AstraZeneca.
Read more at Yahoo Finance: Dow, S&P 500, Nasdaq nudge higher as Wall Street grapples with shutdown risk
